All relevant units: In order to implement the "14th Five-Year Plan" development plan of the national pharmaceutical industry, promote the innovation-driven transformation of the pharmaceutical industry, increase the scale and improve efficiency, boost the pharmaceutical industry in the industrial chain layout to seek steady progress, ensure the level of supply, create new advantages in international competition, and accelerate the realization of high-quality development, the "2022 China Pharmaceutical Industry Technology Annual Conference" hosted by the China Chemical and Pharmaceutical Industry Association and undertaken by The Reed Exhibition of Sinopharm, with the theme of "Innovation-driven Quality Development", will be held on September 26, 2022 in Qingdao, Shandong Province ( During the 88th China International Pharmaceutical API/Intermediate/Packaging/Equipment Fair (API China)
The meeting intends to invite leaders of relevant government departments and relevant experts to make guiding and forward-looking special reports
Conference Theme Innovation-driven Quality Development Organizer: China Chemical and Pharmaceutical Industry Association Organizer: Reed Sinopharm Conference Time and Place Meeting Time: September 26, 2022 (Monday) One Day meeting place: The Westin Qingdao West Coast 3rd Floor Grand Ballroom 2 (No.
7977 Binhai Avenue, Huangdao District, Qingdao, Shandong Province) Registration Time: September 25, 2022 (Sunday) 09:00-22:30 Registration Location: The Westin Qingdao West Coast (No.
7977 Binhai Avenue, Huangdao District, Qingdao, Shandong Province) Conference Topics (1) Leaders' Speeches (2) Special Report 1.
Interpretation of the "14th Five-Year Plan" Pharmaceutical Industry Development Plan —— Department of Consumer Goods Industry, Ministry of Industry and Information Technology 2.
The history and procedure of the adjustment of the national medical insurance catalogue - medical insurance experts 3.
Policies related to drug review and approval - Drug Evaluation Center of the State Drug Administration 4.
The significance of comprehensive clinical evaluation of drugs -- Health Development Research Center of the National Health Commission 5.
Introduction to the content of the outline of the four parts of the 2025 edition of the Chinese Pharmacopoeia - The National Pharmacopoeia Commission 6.
The progress of drug preparation quality research - China Food and Drug Inspection Institute 7.
The trend and direction of China's biotechnology innovation and development - Academician (3) Summary of related matters Registration method and time: In order to ensure the smooth participation, participants are requested to report to the Westin Qingdao West Coast Hotel on September 25 from 09:00 to 22:30 to collect the conference materials